A Cost-Effectiveness Analysis of Vaccinating The Elderly with The 23-Valent Pneumococcal Polysaccharide Vaccine (Ppv23) Compared To No Vaccination, The 13-Valent Pneumococcal Conjugate Vaccine (Pcv13), or Pcv13 Followed by Ppv23 in Brazil

Y Jiang; X Yang; T Petigara; L Chabrol Haas; J Graham

doi:10.1016/j.jval.2017.08.2909

A Cost-Effectiveness Analysis of Vaccinating The Elderly with The 23-Valent Pneumococcal Polysaccharide Vaccine (Ppv23) Compared To No Vaccination, The 13-Valent Pneumococcal Conjugate Vaccine (Pcv13), or Pcv13 Followed by Ppv23 in Brazil

Value in Health ◽

10.1016/j.jval.2017.08.2909 ◽

2017 ◽

Vol 20 (9) ◽

pp. A930 ◽

Cited By ~ 1

Author(s):

Y Jiang ◽

X Yang ◽

T Petigara ◽

L Chabrol Haas ◽

J Graham

Keyword(s):

Cost Effectiveness ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

The Elderly ◽

Cost Effectiveness Analysis ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

Effectiveness Analysis

Get full-text (via PubEx)

VACCINATING OLDER ADULTS IN JAPAN WITH 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23) COMPARED TO 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) OR NO VACCINATION (NOVAC): A COST-EFFECTIVENESS ANALYSIS

10.26226/morressier.5731f0d6d462b8029237fcb3 ◽

2016 ◽

Author(s):

Yiling Jiang

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Cost Effectiveness Analysis ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

Effectiveness Analysis

Get full-text (via PubEx)

VACCINATING OLDER ADULTS IN KOREA WITH 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23) COMPARED TO 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) OR NO VACCINATION (NOVAC): A COST-EFFECTIVENESS ANALYSIS

10.26226/morressier.5731f0d6d462b8029237fcb8 ◽

2016 ◽

Cited By ~ 1

Author(s):

Yiling Jiang

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Cost Effectiveness Analysis ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

Effectiveness Analysis

Get full-text (via PubEx)

CE1 The Cost-Effectiveness Analysis of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Taiwan

Value in Health ◽

10.1016/j.jval.2012.08.003 ◽

2012 ◽

Vol 15 (7) ◽

pp. A602 ◽

Cited By ~ 1

Author(s):

D.B.C. Wu ◽

C.J. Chang ◽

L. Chien ◽

H.C.H. Fang ◽

C.S. Roberts

Keyword(s):

Cost Effectiveness ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Cost Effectiveness Analysis ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

Effectiveness Analysis ◽

The Cost

Get full-text (via PubEx)

A cost-effectiveness analysis of vaccinating older adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) compared to no vaccination, the 13-valent pneumococcal conjugate vaccine (PCV13), or PCV13 followed by PPV23 in Colombia

International Journal of Infectious Diseases ◽

10.1016/j.ijid.2018.04.3456 ◽

2018 ◽

Vol 73 ◽

pp. 13

Author(s):

E. Prieto ◽

Y. Jiang ◽

X. Yang ◽

J.B. Graham ◽

H. Monsanto ◽

...

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Cost Effectiveness Analysis ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

Effectiveness Analysis

Get full-text (via PubEx)

Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea

Human Vaccines & Immunotherapeutics ◽

10.1080/21645515.2018.1456602 ◽

2018 ◽

Vol 14 (8) ◽

pp. 1914-1922 ◽

Cited By ~ 4

Author(s):

Min-Joo Choi ◽

Shin-On Kang ◽

Jin-Jeong Oh ◽

Seong-Beom Park ◽

Min-Ja Kim ◽

...

Keyword(s):

Cost Effectiveness ◽

South Korea ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Adult Population ◽

Cost Effectiveness Analysis ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

Effectiveness Analysis

Get full-text (via PubEx)

Cost-Effectiveness Analysis Of Sequential Vaccination Of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) And 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) On Adult Population In South Korea

Value in Health ◽

10.1016/j.jval.2017.08.2308 ◽

2017 ◽

Vol 20 (9) ◽

pp. A788

Author(s):

D Park ◽

S Kang

Keyword(s):

Cost Effectiveness ◽

South Korea ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Adult Population ◽

Cost Effectiveness Analysis ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

Effectiveness Analysis

Get full-text (via PubEx)

PIN74 A Cost-Effectiveness Analysis of Vaccinating the Elderly with 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Germany

Value in Health ◽

10.1016/j.jval.2011.08.260 ◽

2011 ◽

Vol 14 (7) ◽

pp. A279 ◽

Cited By ~ 1

Author(s):

Y. Jiang ◽

A. Gauthier ◽

L. Annemans ◽

M. van der Linden ◽

L. Nicolas-Spony ◽

...

Keyword(s):

Cost Effectiveness ◽

The Elderly ◽

Cost Effectiveness Analysis ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

Effectiveness Analysis

Get full-text (via PubEx)

PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and at-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or no Vaccination (NoVac) in the UK

Value in Health ◽

10.1016/j.jval.2012.08.1131 ◽

2012 ◽

Vol 15 (7) ◽

pp. A396-A397 ◽

Cited By ~ 1

Author(s):

Y. Jiang ◽

A. Gauthier ◽

S.T. Keeping ◽

S.M. Carroll

Keyword(s):

At Risk ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

The Elderly ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

The Uk ◽

The Cost

Get full-text (via PubEx)

The 23-Valent Pneumococcal Polysaccharide Vaccine. Part II. A Cost-Effectiveness Analysis for Invasive Disease in the Elderly in England and Wales

European Journal of Epidemiology ◽

10.1023/b:ejep.0000024752.48929.bd ◽

2003 ◽

Vol 19 (4) ◽

pp. 365-375 ◽

Cited By ~ 38

Author(s):

Alessia Melegaro ◽

Alessia Melegaro

Keyword(s):

Cost Effectiveness ◽

The Elderly ◽

Invasive Disease ◽

Cost Effectiveness Analysis ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

England And Wales ◽

Effectiveness Analysis

Get full-text (via PubEx)

Cost–effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1586/14737167.2014.950232 ◽

2014 ◽

Vol 14 (6) ◽

pp. 913-927 ◽

Cited By ~ 16

Author(s):

Yiling Jiang ◽

Aline Gauthier ◽

Sam Keeping ◽

Stuart Carroll

Keyword(s):

At Risk ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

The Elderly ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

The Uk

Get full-text (via PubEx)